Skip to main content
Figure 4 | BMC Cancer

Figure 4

From: α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial

Figure 4

Long-term activation of DTH to peptides and KLH through the course of DC vaccinations in patient 2. The responses to each peptide, KLH, and DCs increased to a plateau, and responses to KLH and DCs remained highly positive even more than 2 years after the start of the vaccination, despite that the response to the peptides went down after the vaccinations ceased.

Back to article page